Proposed legislation that would allot $8.75 billion in new NIH grants over the next five years comes at a cost that’s too high in the eyes of critics. They say the bill, backed by the pharmaceutical, biotechnology and medical-device industries, would weaken Food and Drug Administration scrutiny and jeopardize patient safety. Jerry Avorn, professor of medicine at Brigham and Women’s Hospital, is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Researchers Uncover Distinct Zones, Age-Associated Changes in Key Brain Area
Differences in the striatum within and between people enrich map of entire human brain
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?